Sharp Therapeutics Corp. (TSXV: SHRX)
Health Care · Pharmaceuticals · US
CA$—
— today · — 1Y
Sharp Therapeutics Corp. (TSXV: SHRX) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $19.27M.
trading between 0.23 and 5.00.
Tweenvest scores Sharp Therapeutics Corp. across four factors: quality 9/100. Its strongest factor is quality.
SHRX price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.27M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.21
- Dividend yield
- —
- Beta (5Y)
- -0.65
- 52-week high
- CA$5.00
- 52-week low
- CA$0.23
- Avg volume (3M)
- —
- Shares outstanding
- 30.08M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.